Clinical Trials

290 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06417814 2026-03-02

TROPION-Lung15

Phase 3 Recruiting

744 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT03976323 2026-02-25

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

1,003 enrolled 23 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma

NCT03976362 2026-02-25

KEYLYNK-008

851 enrolled 25 charts

Phase 3 Enrolling by invitation

Carcinoma

NCT07311057 2026-01-06

Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy

20 enrolled

Carcinoma, Carcinoma, Squamous Cell

NCT00565851 2025-12-30

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

1,052 enrolled 27 charts

Gynecologic

Brenner Tumor, Carcinoma, Adenocarcinoma, Mucinous, Fallopian Tube Neoplasms, Ovarian Neoplasms, Adenocarcinoma, Clear Cell

NCT03755791 2025-12-11

COSMIC-312

837 enrolled 14 charts

Carcinoma, Carcinoma, Hepatocellular, Neoplasms

NCT03703297 2025-11-21

ADRIATIC

730 enrolled 19 charts 2 FDA

Carcinoma, Lung Neoplasms, Small Cell Lung Carcinoma

NCT03519971 2025-10-28

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

328 enrolled 23 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT04035486 2025-10-10

FLAURA2

587 enrolled 44 charts 2 FDA

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00532155 2025-09-10

VITAL

913 enrolled 16 charts

Carcinoma, Lung Neoplasms

NCT03937219 2025-09-10

COSMIC-313

855 enrolled 12 charts

Phase 3 Not yet recruiting

Carcinoma, Carcinoma, Renal Cell, Neoplasms

NCT07135882 2025-08-22

PRIME-Lung

420 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04879368 2025-07-17

INTEGRATEIIb

450 enrolled

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT03800134 2025-06-11

AEGEAN

825 enrolled 2 FDA

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT05043090 2025-05-08

SAMETA

148 enrolled

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01345084 2025-03-28

NICAP

Phase 3 Withdrawn

Carcinoma, Head and Neck Neoplasms

NCT00051545 2025-02-25

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

608 enrolled

Carcinoma, Liver Neoplasms, Neoplasms

NCT04747054 2024-10-26

PembroMetaRT

Phase 3 Recruiting

102 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Neoplasm Metastasis

NCT02112656 2024-08-20

OPTIMA

554 enrolled 9 charts

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT04816214 2024-03-05

GEOMETRY-E

6 enrolled 20 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02539537 2024-01-09

NEOPAN

171 enrolled

Carcinoma, Pancreatic Neoplasms

NCT00606866 2023-11-29

MRI

57 enrolled

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT03626545 2023-08-21

CANOPY-2

245 enrolled 29 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT03952403 2023-08-08

A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

643 enrolled

Carcinoma

NCT02915744 2023-04-14

ATTAIN

178 enrolled 37 charts

Breast

Breast Neoplasms, Carcinoma, Neoplasm Metastasis

NCT01855451 2022-11-18

HPVOropharynx

189 enrolled

Carcinoma

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

1,613 enrolled

Breast

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT00198315 2022-03-04

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

130 enrolled

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT00198328 2022-03-04

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

84 enrolled

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

NCT02773524 2022-01-13

INTEGRATEIIa

250 enrolled

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT02737501 2021-08-20

ALTA-1L

275 enrolled 23 charts 2 FDA

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

NCT02367781 2021-08-09

IMpower130

723 enrolled 28 charts 1 FDA

Carcinoma

NCT01755767 2021-04-06

METIV-HCC

383 enrolled 17 charts

Carcinoma, Carcinoma, Hepatocellular

NCT02526953 2021-02-09

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

314 enrolled

Anus Diseases, Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Neoplasms, Squamous Cell

NCT02793128 2020-12-22

Olympus

71 enrolled 16 charts 1 FDA

Carcinoma, Carcinoma, Transitional Cell

NCT04225299 2020-11-13

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Phase 3 Withdrawn

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT00216372 2020-11-05

Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis

80 enrolled

Gynecologic

Carcinoma, Intestinal Obstruction, Peritoneal Neoplasms

NCT00880971 2020-10-05

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

394 enrolled